MAPK/NF-κB-dependent upregulation of kinin receptors mediates airway hyperreactivity: A new perspective for the treatment

作者: Yaping Zhang , Lars-Olaf Cardell , Lars Edvinsson , Cang-Bao Xu

DOI: 10.1016/J.PHRS.2013.02.004

关键词: Signal transductionTLR4IκB kinaseReceptor expressionMAPK/ERK pathwayPharmacologyKininChemistryDownregulation and upregulationG protein-coupled receptor

摘要: Airway hyperreactivity (AHR) is a major feature of asthmatic and inflammatory airways. Cigarette smoke exposure, bacterial viral infections are well-known environmental risk factors for AHR, but knowledge about the underlying molecular mechanisms on how these lead to development AHR limited. Activation intracellular mitogen-activated protein kinase (MAPK)/nuclear factor-kappa B (NF-kappa B) their related signal pathways including C (PKC), phosphoinositide 3-kinase (PI3K) A (PKA) signaling may result in airway kinin receptor upregulation, which suggested play an important role AHR. Environmental trigger production pro-inflammatory mediators such as tumor necrosis factor-alpha (TNF-alpha) interleukins (ILs) that activate MAPK- NF-kappa B-dependent pathways, subsequently via upregulation. Blockage MAPK/NF-kappa prevents B-1 B-2 expression airways, resulting decrease response bradykinin (kinin agonist) des-Arg(9)-bradykinin agonist). This suggests upregulation can provide novel option treatment well other diseases. (C) 2013 Elsevier Ltd. All rights reserved. (Less)

参考文章(158)
A. Rosenhagen, M. Bernhörster, L. Vogt, W. Banzer, C. Thiel, Recurrent childhood wheezing and exercise induced asthma in later life. Journal of Sports Medicine and Physical Fitness. ,vol. 52, pp. 661- 664 ,(2012)
Fabio Martinon, Kimberly Burns, Jürg Tschopp, The Inflammasome Molecular Cell. ,vol. 10, pp. 417- 426 ,(2002) , 10.1016/S1097-2765(02)00599-3
Jim Jung‐Ching Lin, Yan Li, Robbin D. Eppinga, Qinchuan Wang, Jian‐Ping Jin, Chapter 1 Roles of Caldesmon in Cell Motility and Actin Cytoskeleton Remodeling International Review of Cell and Molecular Biology. ,vol. 274, pp. 1- 68 ,(2009) , 10.1016/S1937-6448(08)02001-7
Jean Kim, Scherer P. Sanders, Edward S. Siekierski, Vincenzo Casolaro, David Proud, Role of NF-κB in Cytokine Production Induced from Human Airway Epithelial Cells by Rhinovirus Infection Journal of Immunology. ,vol. 165, pp. 3384- 3392 ,(2000) , 10.4049/JIMMUNOL.165.6.3384
A Faussner, S Schüssler, J Feierler, M Bermudez, J Pfeifer, K Schnatbaum, T Tradler, M Jochum, G Wolber, C Gibson, Binding characteristics of [3H]-JSM10292: a new cell membrane-permeant non-peptide bradykinin B2 receptor antagonist British Journal of Pharmacology. ,vol. 167, pp. 839- 853 ,(2012) , 10.1111/J.1476-5381.2012.02054.X
Cang-Bao Xu, Ying Lei, Qingwen Chen, Christina Pehrson, Lennart Larsson, Lars Edvinsson, Cigarette smoke extracts promote vascular smooth muscle cell proliferation and enhances contractile responses in the vasculature and airway. Basic & Clinical Pharmacology & Toxicology. ,vol. 107, pp. 940- 948 ,(2010) , 10.1111/J.1742-7843.2010.00610.X
P J Barnes, N Frossard, K J Rhoden, Influence of epithelium on guinea pig airway responses to tachykinins: role of endopeptidase and cyclooxygenase. Journal of Pharmacology and Experimental Therapeutics. ,vol. 248, pp. 292- 298 ,(1989)
Xiuxia Zhou, Haizhen Hu, Silvana Balzar, John B. Trudeau, Sally E. Wenzel, MAPK Regulation of IL-4/IL-13 Receptors Contributes to the Synergistic Increase in CCL11/Eotaxin-1 in Response to TGF-β1 and IL-13 in Human Airway Fibroblasts Journal of Immunology. ,vol. 188, pp. 6046- 6054 ,(2012) , 10.4049/JIMMUNOL.1102760
Melanie Königshoff, Oliver Eickelberg, WNT signaling in lung disease: a failure or a regeneration signal? American Journal of Respiratory Cell and Molecular Biology. ,vol. 42, pp. 21- 31 ,(2010) , 10.1165/RCMB.2008-0485TR
Sandra C. Christiansen, Jane Eddleston, Katharine M. Woessner, Sandra S. Chambers, Richard Ye, Zhixing K. Pan, Bruce L. Zuraw, Up-Regulation of Functional Kinin B1 Receptors in Allergic Airway Inflammation Journal of Immunology. ,vol. 169, pp. 2054- 2060 ,(2002) , 10.4049/JIMMUNOL.169.4.2054